Global In-Vitro Diagnostics (IVD) Market Report: 2014 Edition


#242777

64pages

Koncept Analytics

$ 800

In Stock

An in-vitro diagnostic test is performed outside of a human body in an artificial environment (e.g. laboratory). IVD is considered as an essential part of today’s healthcare. The IVD products are broadly divided into three categories: reagents, analytical instruments and accessory products. IVD is widely used for diagnosis, monitoring of prescribed treatments and assessment of medical intervention, apart from others thereby contributing to availability of medical information regarding a patient. Furthermore, IVD allows earlier and more targeted treatment which in turn leads to reduced hospital stays and convalescences resulting in a healthier population and economic growth in the long run.

A constant growth has been observed in the global IVD industry since 2009. In IVD by technology, immunoassay and conventional chemistry strongly dominates the market. Laboratory test lead the IVD market by test location followed by self-test. Infectious disease is the largest segment covering the IVD market. On the basis of IVD products, reagent has the maximum market share.

The key factors which are anticipated to drive market growth include rising global healthcare expense, increasing global ageing population, accelerating global diabetic population apart from rising incidences of chronic and infectious diseases and increasing global gross national income. Some of the noteworthy developments of this industry include food safety testing market being taken over, development in patient monitoring and telemedicine, continued expansion of POC testing apart from mergers and acquisitions. However, the industry remains threatened by certain challenges which include lack of economies of scale and scope, increase in investment demands apart from usual regulatory, reimbursement and intellectual property issues.

This report offers a comprehensive analysis of the global in-vitro diagnostic market, along with an in-depth study of the IVD segments and the regional markets of Europe and China. The global IVD industry is consolidated with the top players, Abbott, Siemens, Roche and Johnson and Johnson which operate in a highly competitive environment. The above mentioned companies are being profiled along with their key financials and strategies for growth.

By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests. 

1. Overview
1.1 Types of IVD Products
1.2 Types of IVD Tests
1.3 Market Segments
1.3.1 Technology Type
1.3.2 End-User Segmentation
1.4 Uses of IVDs
1.5 IVD Value Chain

2. IVD Market Size
2.1 Global Market
2.1.1 IVD Market by Technology Type
2.1.2 IVD Market by Test Location
2.1.3 IVD Market by Disease Area
2.1.4 IVD Market by Product Type
2.2 Molecular Diagnostics
  • by Technology Type
  • by Test Location
  • by Therapeutic Area
2.3 Regional Markets
2.3.1 Europe
  • Market Value
  • Breakdown by Countries
  • Other Statistics by Countries
2.3.2 China
  • Market Value
  • Market Segmentation
3. Market Dynamics
3.1 Growth Drivers
3.1.1 Rising Global Healthcare Expense
3.1.2 Increasing Global Ageing Population
3.1.3 Accelerating Global Diabetic Population
3.1.4 Rising Incidences of Chronic and Infectious Diseases
3.1.5 Increasing Global Gross National Income
3.2 Challenges
3.2.1 Regulatory, Reimbursement, and Intellectual Property (IP) Arenas
3.2.2 Lack of Economies of Scale and Scope
3.2.3 Increase in Investment Demands
3.3 Key Trends
3.3.1 Food Safety Testing Market Taken Over by MDx and Immunoassays
3.3.2 Development in Patient Monitoring and Telemedicine
3.3.3 Continued Expansion of Point of Care Testing
3.3.4 Mergers and Acquisitions

4. Competitive Landscape
4.1 Global Market
4.2 Competition by Company Performance
4.2.1 IVD Sales
4.2.2 Reported Growth
4.2.3 Organic Growth
4.3 Competition by Segments
4.3.1 Professional Diagnostic
4.3.2 Home Blood Glucose Monitoring (HBGM)
4.3.3 Conventional Microbiology
4.3.4 Flow Cytometry
4.3.4 Molecular Diagnostic

5. Company Profiles
5.1 Abbott Laboratories
5.1.1 Business Overview
5.1.2 Financial Overview
5.1.3 Business Strategies
  • Business Diversification
  • Expansion through Acquisitions
5.2 Siemens AG
5.2.1 Business Overview
5.2.2 Financial Overview
5.2.3 Business Strategies
  • Focus on Research & Development
  • Expanding Global Presence
5.3 Roche Holdings AG
5.3.1 Business Overview
5.3.2 Financial Overview
5.3.3 Business Strategies
  • Strengthening through Acquisitions
  • Ceaseless Focus on R&D
5.4 Johnson & Johnson
5.4.1 Business Overview
5.4.2 Financial Overview
5.4.3 Business Strategies
  • Creating Value through Innovation
  • Increasing Global Reach
6. Market Outlook
6.1 Market Forecast
6.2 Forecast Methodology
6.2.1 Dependent and Independent Variables
6.2.2 Correlation Analysis
6.2.3 Regression Analysis  

IVD Market Key Players-by Segments
Country-wise Division of European IVD Market (2013)
Mergers and Acquisitions (2006-2014)
Global In-Vitro Diagnostic Sales of Market Players (2013-3Q14)
Reported Growth of IVD Players (2013-3Q14)
Ex-FX/ Organic Growth of IVD Players (2013-3Q14)
Dependent & Independent Variables (2009–2013)
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output 

IVD Market Segments by Technology Type
IVD Market by End Users
IVD Value Chain Analysis in Medical Application
Global In-Vitro Diagnostics Market (2009-2013)
IVD Market by Technology Type (2013)
IVD Market by Test Location (2013)
IVD Market by Disease Area (2013)
IVD Market by Products (2013)
Molecular Diagnostic Market Size (2011-2013)
Molecular Diagnostic Market by Technology Type (2013)
Molecular Diagnostic Market by Test Location (2013)
Molecular Diagnostic Market Therapeutic Area (2013)
IVD Market by Region (2013)
IVD Market of EU27+ EFTA (2009-2013)
IVD Market in Europe (2009-2013)
European IVD Market – by Countries (2013)
IVD Market Share in Europe – by Countries (2013)
IVD Market in China (2009-2013)
Domestic IVD Market of China (2013)
Global Health Care Expenditure Per Capita (2008-2013E)
Global Ageing Population (65 years and above) (2009-2013)
World Population with Diabetes, Age Group 20-79 years (2009-2013)
Global Gross National Income Per Capita (2009-2013)
MDx and Immunoassays Taking over Food Safety Testing Market
Global IVD Market – Share Breakdown by Company (2013)
Professional Diagnostic Market Share (2013)
HBGM Market Share (2013)
Conventional Microbiology Market Share (2013)
Flow Cytometry Market (2013)
Molecular Diagnostic Market Share (2013)
Abbott Laboratories Revenue Share by Business Unit (2013)
Abbott Laboratories Revenue and Net Income (2009-2013)
Siemens Revenue Share by Sectors (2014)
Siemens Revenue and Net Income (2010-2014)
Roche’s Revenue Share by Divisions (2013)
Roche’s Revenue and Net Income (2009-2013)
Sales of Johnson & Johnson’s by Business Segments (2013)
Revenues and Net Income of Johnson & Johnson (2010-2013)
Global In Vitro Diagnostics Market (2013-2017F)